Arianne Morissette - Publications

Sex- and stressor-dependent effects of metformin on cardiac fibrosis in plasminogen activator inhibitor-1 deficiency.

Journal: Journal of molecular and cellular cardiology

Published: February 13, 2026

Impacts of ketogenic diet intervention on cardiometabolic outcomes in obese, dysglycemic mice.

Journal: Cardiovascular diabetology

Published: October 03, 2025

Intestinal adaptation to cold-induced metabolic demand and feeding requires GLP-1R and GLP-2R signalling.

Journal: Communications biology

Published: April 09, 2025

Cardioprotective benefits of metabolic surgery and GLP-1 receptor agonist-based therapies.

Journal: Trends in endocrinology and metabolism: TEM

Published: May 10, 2024

Obesity management for the treatment of type 2 diabetes: emerging evidence and therapeutic approaches.

Journal: Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques

Published: March 30, 2024

Metabolic-associated fatty liver disease is characterized by a post-oral glucose load hyperinsulinemia in individuals with mild metabolic alterations.

Journal: American journal of physiology. Endocrinology and metabolism

Published: March 13, 2024

Substituting Refined Sugars With Maple Syrup Decreases Key Cardiometabolic Risk Factors in Individuals With Mild Metabolic Alterations: A Randomized, Double-Blind, Controlled Crossover Trial.

Journal: The Journal of nutrition

Published: March 07, 2024

GLP-1 receptor agonist-based therapies and cardiovascular risk: a review of mechanisms.

Journal: The Journal of endocrinology

Published: February 15, 2024

Immunomodulation and inflammation: Role of GLP-1R and GIPR expressing cells within the gut.

Journal: Peptides

Published: January 26, 2024

The metabolic benefits of substituting sucrose for maple syrup are associated with a shift in carbohydrate digestion and gut microbiota composition in high-fat high-sucrose diet-fed mice.

Journal: American journal of physiology. Endocrinology and metabolism

Published: October 25, 2023

Rebaudioside D decreases adiposity and hepatic lipid accumulation in a mouse model of obesity.

Journal: Scientific reports

Published: March 28, 2023

Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals: A randomized crossover trial.

Journal: Cell reports. Medicine

Published: March 20, 2023